Evaluation of the frequency of resistance to 2 drugs (Isoniazid and Rifampin) by molecular investigation and it's risk factors in new cases of smear positive pulmonary tuberculosis in health centers under the cover of Jundishapur University of Medical Sciences in 2017
Introduction: Despite the great efforts to control tuberculosis (TB), the disease is still one of the major health challenges throughout the world. The basic treatment for TB is drug therapy. Currently, the main anti-tuberculosis drugs with major use in the treatment and control of the disease are i...
Main Authors: | Shokrollah Salmanzadeh, Masoumeh Karamian, Seyed Mohammad Alavi, Roohangiz Nashibi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Journal of Family Medicine and Primary Care |
Subjects: | |
Online Access: | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2020;volume=9;issue=4;spage=1958;epage=1962;aulast=Salmanzadeh |
Similar Items
-
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in <it>Mycobacterium tuberculosis</it>
by: Parsons Linda M, et al.
Published: (2001-04-01) -
Molecular detection of rifampin, isoniazid, and ofloxacin resistance in Iranian isolates of Mycobacterium tuberculosis by high-resolution melting analysis
by: Sirous M, et al.
Published: (2018-10-01) -
Evidenziazione molecolare di resistenza di Mycobacterium tuberculosis complex a rifampicina e isoniazide
by: Gian Lorenzo Molinari, et al.
Published: (2006-06-01) -
Intestinal permeability and malabsorption of rifampin and isoniazid in active pulmonary tuberculosis
by: Valéria G. F. Pinheiro, et al. -
Transdermal delivery of isoniazid and rifampin in guinea pigs by electro-phonophoresis
by: Suting Chen, et al.
Published: (2017-01-01)